NL-OMON55606
Completed
Phase 4
The effect of bariatric surgery on pharmacotherapy of psychotropic drugs in clinical practice - The effect of bariatric surgery on pharmacotherapy of psychotropic drugs
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Sint Antonius Ziekenhuis
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •In order to be eligible to participate in this study, a subject must meet all
- •of the following criteria:, \- Indication for bariatric surgery (i.e. Body Mass
- •Index (BMI) \> 40 kg/m2 or BMI\> 35 kg/m2 with additional risk factors) at St
- •Antonius hospital. Bariatric surgery includes the following procedures:
- •laparoscopic (mini\-) gastric bypass or laparoscopic sleeve gastrectomy;
- •\- Participant \>\= 18 years, who uses one of de following psychotropic drugs\* for
- •anxiety and depression;
- •\- ASA physical classification II or III;
- •\- Participant is able and willing to sign the Informed Consent form before the
- •\- Intake and follow up by the Dutch Obesity Clinic (in groups sessions);
Exclusion Criteria
- •A potential subject who meets any of the following criteria will be excluded
- •from participation in this study:
- •\- Known allergy for the administered medicine;
- •\- Pregnancy or breast\-feeding. This is an exclusion criterion for bariatric
- •surgery (participants are informed by their surgeon and bariatric nurse). Women
- •of childbearing age who use contraceptive methods are allowed to participate in
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Not Applicable
The effect of bariatric surgery on pharmacotherapy of psychotropic drugsNL-OMON29532St Antonius hospital
Withdrawn
Not Applicable
The effect of bariatric surgery on the pharmacokinetics of venlafaxinebariatrische chirurgieBariatric surgerydepression10027946NL-OMON47961Maasstadziekenhuis12
Not yet recruiting
Not Applicable
Study of the therapeutic effects of bariatric surgery for severe obesitysevere obesityJPRN-UMIN000041014Tottori University Faculty of Medicine, Division of Cardiovascular Medicine and Endocrinology and Me20
Completed
Phase 4
The influence of having bariatric surgery on the pharmacokinetics, safety and efficacy of the novel non-nucleoside reverse transcriptase inhibitor doravirine (LABRADOR)NL-OMON51582Afdeling Apotheek1
Active, not recruiting
Phase 1
Exposure to Doravirine in people with HIV undergoing weight loss surgeryHIV plus bariatric surgeryMedDRA version: 20.1Level: LLTClassification code 10068341Term: HIV-1 infectionSystem Organ Class: 100000004862MedDRA version: 21.1Level: LLTClassification code 10068900Term: Bariatric surgerySystem Organ Class: 100000004865Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Surgical Procedures, Operative [E04]EUCTR2021-005347-79-NLRadboud University Medical Center8